P-Glycoprotein expression in human retinal pigment epithelium cell lines

被引:53
作者
Constable, Paul A.
Lawrenson, John G.
Dolman, Diana E. M.
Arden, Geoffrey B.
Abbott, N. Joan
机构
[1] City Univ London, Dept Optometry & Visual Sci, Henry Welllcome Labs Vis Sci, Appl Vis Res Ctr, London EC1V 0HB, England
[2] Kings Coll London, Wolfson Ctr Age Related Dis, London, England
基金
英国惠康基金;
关键词
P-glycoprotein; retinal pigment epithelium; cell lines; drug transport;
D O I
10.1016/j.exer.2005.10.029
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
P-Glycoprotein (P-gp), an active efflux transporter encoded by the MDR1 gene, has recently been identified in the human and pig retinal pigment epithelium (RPE) in situ. Efflux pumps such as P-gp are major barriers to drug delivery in several tissues. We wished to establish whether human RPE cell lines express P-gp under the culture conditions recommended for each cell line so as to determine their suitability as in vitro models for predicting drug transport across the outer blood-retinal barrier. Three human RPE cell lines, ARPE19, D407 and h1RPE were investigated. Reverse transcriptase-polymerase chain reaction (RT-PCR) was carried out to determine the expression of MDR1 mRNA. Immunocytochemistry using the P-gp-specific antibody C219 was undertaken to investigate the presence of P-gp protein in each cell type. Uptake of rhodamine 123, a P-gp substrate, in the presence or absence of pre-treatment with a P-gp inhibitor, verapamil, was measured in each cell line to determine functional expression of P-gp. For all experiments, MDCK cells stably transfected with the human MDR1 gene (MDCK-MDR1) were used as a positive control. ARPE19 cells were consistently negative for P-gp as assessed by RT-PCR and immunocytochemistry. By contrast, RT-PCR of D407 and h1RPE samples yielded weak bands corresponding to MDR1; P-gp protein expression, as demonstrated by C219 immunoreactivity, was also present. Rhodamine uptake after treatment with verapamil was significantly greater in D407 and MDCK-MDR1, indicating functional expression of P-gp in these two cell lines. No evidence of functional P-gp was found in ARPE19 and h1RPE. In conclusion, D407 and h1RPE cells express P-gp, though functional activity was demonstrable only in D407 cells. ARPE19 cells do not express P-gp. Of these human RPE cells lines D407 could be considered as a suitable model for in vitro drug transport studies, particularly those involving P-gp substrates, without modification of their usual culture conditions. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:24 / 30
页数:7
相关论文
共 33 条
  • [1] Transscleral drug delivery to the retina and choroid
    Ambati, J
    Adamis, AP
    [J]. PROGRESS IN RETINAL AND EYE RESEARCH, 2002, 21 (02) : 145 - 151
  • [2] Expression of multidrug resistance-associated protein (MRP) in human retinal pigment epithelial cells and its interaction with BAPSG, a novel aldose reductase inhibitor
    Aukunuru, JV
    Sunkara, G
    Bandi, N
    Thoreson, WB
    Kompella, UB
    [J]. PHARMACEUTICAL RESEARCH, 2001, 18 (05) : 565 - 572
  • [3] Begley DJ, 1996, J NEUROCHEM, V67, P988
  • [4] The blood-retinal barriers system. Basic concepts and clinical evaluation
    Cunha-Vaz, JG
    [J]. EXPERIMENTAL EYE RESEARCH, 2004, 78 (03) : 715 - 721
  • [5] DAVIS AA, 1995, INVEST OPHTH VIS SCI, V36, P955
  • [6] Dunn KC, 1998, INVEST OPHTH VIS SCI, V39, P2744
  • [7] ARPE-19, a human retinal pigment epithelial cell line with differentiated properties
    Dunn, KC
    AotakiKeen, AE
    Putkey, FR
    Hjelmeland, LM
    [J]. EXPERIMENTAL EYE RESEARCH, 1996, 62 (02) : 155 - 169
  • [8] Drug delivery to the retina: challenges and opportunities
    Duvvuri, S
    Majumdar, S
    Mitra, AK
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2003, 3 (01) : 45 - 56
  • [9] Esser P, 1998, INVEST OPHTH VIS SCI, V39, P164
  • [10] Astrocytes increase the functional expression of P-glycoprotein in an in vitro model of the blood-brain barrier
    Gaillard, PJ
    van der Sandt, ICJ
    Voorwinden, LH
    Vu, D
    Nielsen, JL
    de Boer, AG
    Breimer, DD
    [J]. PHARMACEUTICAL RESEARCH, 2000, 17 (10) : 1198 - 1205